Funding
Current
FONDECYT regular 1221436 Adenosine Deaminase RNA Specific (ADAR) regulates the breast cancer drug response (2022-2026).
FONDECYT regular 1221162 Unraveling the mechanism behind ski-dependent tri-methylation of LYS9 in histone H3 in pericentric heterochromatin and its role in the maintenance of genome stability (2022-2026).
Anillo ACT210079 Landscape of Clinically actionable Cancer Genes: Towards precisión oncology in Chile (2021-2024).
FONDEF IDeA I+D ID21I10355 Desarrollo y Validación a pequeña escala de un ensayo para la detección de mutaciones tumorales en biopsia líquida en pacientes con cáncer de mama avanzado (2021-2023).
FONDECYT Postdoctorate 3210455 Uncovering novel driver mutations in non-small cell lung cancer from Chile, Brazil, and Peru patients (2021-2023), PI Dr. Solange Rivas.
ROCHE/GOCCHI SL43064. Discovery of novel actionable genomic alterations in South America patients (2021-2022).
Past
Atracción de Centros de Excelencia Internacionales de I+D, CEI 2.0 “Center for Excellence in Precision Medicine, Pfizer Chile” CORFO 2013-21602-1-INNOVA (2014 – 2019).
FONDECYT 1151435 “Role of Ski/Smad4 complex on the establishment of epigenetic modifications of pericentromeric chromatin required for proper chromosome segregation” (2015 – 2019).
FONDECYT 1151446 “ADAR promotes breast cancer progression through the regulation of cell cycle and DNA repair related genes” (2015 – 2019).
FONDEQUIP 116363 “Instalación de una plataforma de genómica multipropósito en la Universidad de Chile: Illumina NextSeq 550” (2015).
FONDEQUIP 116816 “Sistema de Almacenamiento y Servicios Informáticos Biomédicos Avanzados (SASIBA Data Center)” (2015).
Fondo Excelencia Académica Universidad de Chile “Biobanco Facultad de Medicina-HCUCH: Alianza estratégica entre la Facultad de Medicina - Hospital Clínico” (2015).
National Cancer Institute, NIH, EEUU, “Pilot Collaborations with LMICs in Global Cancer Research or Global Health Research at NCI-Designated Cancer Centers: Training Chilean Bioinformatics Researchers in the Cancer Genomics field” (2014 - 2016).
Programa de Cooperación Internacional CONICYT Apoyo a la Formación de Redes Internacionales entre Centros de Investigación REDES130114 “Centro Internacional de Genomica del Cancer UChile-FIMM” (2014- -).
FONDECYT postdoctorate 3150292 Role of the unfolded protein response (UPR) in the progression of breast cancer. Distinct effects on tumor growth and metastasis (2014- -), PI Dra. Rosula García.
FONDECYT postdoctorate 3140448 “Lipopolysaccharide induces epithelial- mesenchymal transition of the bladder urothelium” (2013 - 2016), PI Dr. Cesar Echeverria.
Anillo in Science and Technology ACT 1115 “Plasma Physics, Pulsed Power and Cell Biology for Energy, Life and Environment (2013 - 2016).
CONICYT REDCIENCIA 120003 “Red U-Cáncer, una plataforma en línea de investigación básico-clínico de cáncer en Chile” (2013).
FONDEF of public interest D11I1029 “Incorporating next generation sequencing into cancer patient care” (2013 - 2016).
U-Redes Domeyko II CONRED-2012-999 “BioMed-HPC: Red de biología y medicina computacional de alto rendimiento" (2013 - 2015).
United States Latin American Cancer Research Network, National Cancer Institute, NIH, EEUU, Contract No. HHSN261200800001E “Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard of Care Treatment” (2013 - 2015).
FONDECYT 1120132 “Protein kinase CK2 promotes colon cancer metastasis by increasing the expression of Endothelin-Converting Enzyme-1 isoform c (ECE-1c)” (2012 - 2015).
FONDECYT 1120222 "Ski-containing transcriptional co-repressor complexes on mitotic chromosomes repress the expression of selected target genes at early G1" (2012 - 2015).
FONDECYT 1120286 “The Transient Receptor Potential Melastatin 4 (TRPM4) channel stabilizes b-catenin and therefore enhances cell proliferation through a calcium-dependent negative regulation of GSK-3b activity” (2012 - 2015).
U-Redes Domeyko II, Vicerrectoría de Investigación, Universidad de Chile, “U-CANCER: Red de Medicina Traslacional en Cáncer” (2012-2014)
FONDAP 15010006 “Centro de Estudios Moleculares de la Célula” (2006-2011).